SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: willy61 who wrote (8415)12/3/2009 7:52:12 PM
From: li3511  Read Replies (1) | Respond to of 63332
 
> June, when UCB announces these results

Say WHAT? Where is THIS from?

UCB supposedly had the data in decent enough shape to ask for a late-breaker slot at the ACR meeting -- call it October 20. They ought to be able to write it up and get it published in a peer-reviewed Journal before June. In the current issue of Rheumatology, for example, the time between paper submission and electronic (on-line) publication seems to be about 5 to 8 months.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News